| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/19/2015 | US20150050278 Soluble engineered monomeric fc |
| 02/19/2015 | US20150050256 Class I and II Lantibiotics from Geobacillus thermodenitrificans |
| 02/19/2015 | US20150050250 Cell therapy technology to deliver radio-protective peptides |
| 02/19/2015 | US20150050215 Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease |
| 02/19/2015 | US20150048513 Method for obtaining three-dimensional actin structures and uses thereof |
| 02/19/2015 | US20150047532 Synthetic spider silk protein compositions and methods |
| 02/18/2015 | EP2837938A1 C1q-ADIPONECTIN COMPLEX AND USE THEREOF |
| 02/18/2015 | EP2837383A1 Immunity-inducing agent |
| 02/18/2015 | EP2837377A1 Lyophilization of synthetic liposomal pulmonary surfactant |
| 02/18/2015 | EP2837373A1 Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof |
| 02/18/2015 | EP2836591A1 Methods for generation of pluripotent and multipotent cells |
| 02/18/2015 | EP2836511A1 Polypeptide useful in adoptive cell therapy |
| 02/18/2015 | EP2836510A1 Polypeptides as apelin inhibitors and uses thereof |
| 02/18/2015 | EP2836509A1 Mutations in calmodulin genes |
| 02/18/2015 | EP2836508A2 Insulin formulations |
| 02/18/2015 | EP2836507A2 Sortase- modified vhh domains and uses thereof |
| 02/18/2015 | EP2836506A1 Mutant lysenin pores |
| 02/18/2015 | EP2836505A1 Human respiratory syncytial virus concensus antigens, nucleic acid constructs and vaccines made thereform, and methods of using same |
| 02/18/2015 | EP2836239A1 Chimeric antigen receptors targeting b-cell maturation antigen |
| 02/18/2015 | EP2836231A1 Genetically stable live attenuated respiratory syncytial virus vaccine and its production |
| 02/18/2015 | EP2836229A1 Liposomes containing oligopeptide fragments of myelin basic protein, a pharmaceutical composition and a method for treatment of multiple sclerosis |
| 02/18/2015 | EP2836195A1 System and method for multiphasic release of growth factors |
| 02/17/2015 | US8957288 Tomato Line FDS 17-APER |
| 02/17/2015 | US8957287 Tomato line PSQ-9Z09042 |
| 02/17/2015 | US8957282 Yield and stress tolerance in transgenic plants IV |
| 02/17/2015 | US8957192 Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1 |
| 02/17/2015 | US8957190 Use of heat-resistant biotin-binding protein, and solid support having the protein attached thereto |
| 02/17/2015 | US8957189 Multi-site modified SP1 polypeptides and uses thereof |
| 02/17/2015 | US8957185 MUC-1 cytoplasmic domain peptides as inhibitors of cancer |
| 02/17/2015 | US8957184 Pro-apoptotic peptides |
| 02/17/2015 | US8957036 Targeted delivery of glycine receptors to excitable cells |
| 02/17/2015 | US8957029 Peptide for determining actin structures in living cells |
| 02/17/2015 | US8957028 Red-shifted opsin molecules and uses thereof |
| 02/17/2015 | US8957026 Beta-catenin targeting peptides and uses thereof |
| 02/17/2015 | US8957024 Composition and methods for reducing opioid-induced pruritus |
| 02/17/2015 | US8957023 Methods for making proteins containing free cysteine residues |
| 02/17/2015 | US8957021 Glucose-regulating polypeptides and methods of making and using same |
| 02/17/2015 | US8957019 Oligopeptide for treating liver fibrosis and/or treating hepatitis B and/or improving liver function |
| 02/17/2015 | US8957018 Recombinant human CC10 protein for treatment of influenza |
| 02/17/2015 | US8956878 Polypeptides with affinity for heat shock proteins (HSPS) and HSP associated complexes (HACS) and their use in diagnosis and therapy |
| 02/17/2015 | US8956849 Compositions and methods of enhancing immune responses to Eimeria |
| 02/17/2015 | US8956847 Fusion proteins |
| 02/17/2015 | US8956829 Human recombinant growth and differentiaton factor-5 (rhGDF-5) |
| 02/17/2015 | US8956824 Methods for identifying allosteric modulators of ship polypeptides |
| 02/17/2015 | US8956818 Proteoglycan splice variants as therapeutics and diagnostics for amyloid diseases |
| 02/17/2015 | US8956812 Process for the preparation and purification of recombinant proteins |
| 02/17/2015 | US8956627 Method of inducing antibodies to human immunodeficiency virus involving the administration of MPER peptide-liposome conjugates |
| 02/17/2015 | US8956626 Modified viral strains and method for improving the production of vaccine seeds of influenza virus |
| 02/17/2015 | US8956623 Recombinant fusion interferon for animals |
| 02/17/2015 | US8956622 Peptidic antagonists of class III semaphorins/neuropilins complexes |
| 02/17/2015 | US8956621 Compositions and methods for treatment of cervical dysplasia |
| 02/17/2015 | US8956620 Anti-HIV vaccine constructed based on amino acid mutations in attenuated live EIAV vaccine |
| 02/17/2015 | US8956619 Soluble CD80 as a therapeutic to reverse immune supression in cancer patients |
| 02/17/2015 | US8956616 Constructs binding to phosphatidylserine and their use in disease treatment |
| 02/17/2015 | US8956612 Peptide associated with rheumatic fever (PARF) and its use as a diagnostic marker |
| 02/17/2015 | US8956605 Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-22 |
| 02/17/2015 | CA2776522C Development of a preventive vaccine for filovirus infection in primates |
| 02/17/2015 | CA2727317C Melanocortin receptor-specific peptides for treatment of sexual dysfunction |
| 02/17/2015 | CA2669524C Collagen peptide composition and food or beverage containing the same |
| 02/17/2015 | CA2595901C Axmi-018, axmi-020, and axmi-021, a family of delta-endotoxin genes and methods for their use |
| 02/17/2015 | CA2576963C Sequential protein isolation and purification schemes by affinity chromatography |
| 02/17/2015 | CA2567111C Methods and agents for screening for compounds capable of modulating vegf expression |
| 02/17/2015 | CA2557151C Peptide analogues of gip for treatment of diabetes, insulin resistance and obesity |
| 02/17/2015 | CA2541006C Tim-3 polypeptides |
| 02/17/2015 | CA2511814C Polymer conjugates of interferon-beta with enhanced biological potency |
| 02/17/2015 | CA2506331C Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 02/17/2015 | CA2506129C 2'-branched nucleosides and flaviviridae mutation |
| 02/17/2015 | CA2494384C A segment of glycosylation-deficient hgf .alpha.-chain |
| 02/12/2015 | WO2015021465A2 Protein engineered systems for delivery of molecules |
| 02/12/2015 | WO2015021165A1 Method of diagnosing sepsis or sepsis risk |
| 02/12/2015 | WO2015021061A2 Compositions and methods for treating smooth muscle dysfunction |
| 02/12/2015 | WO2015020913A2 Influenza hemagglutinin proteins and methods of thereof |
| 02/12/2015 | WO2015020559A1 Composition for enhancing transgene expression in eukaryotic cells and method for enhancing production of a target protein encoded by a transgene |
| 02/12/2015 | WO2015020522A1 Recombinant aav-crumbs homologue composition and methods for treating lca-8 and progressive rp |
| 02/12/2015 | WO2015020218A1 Highly-active tale protein by altering dna-bound protein domain |
| 02/12/2015 | WO2015019979A1 Biomarker related to schizophrenia |
| 02/12/2015 | WO2015019951A1 Method of amplifying nucleic acid |
| 02/12/2015 | WO2015019672A1 Polypeptide containing dna-binding domain |
| 02/12/2015 | WO2015019376A1 Synthetic cyclic peptides, agonists and antagonists of urotensin-ii and process for the production thereof |
| 02/12/2015 | WO2015019125A1 Molecular targets for the treatment of wounds, in particular chronic wounds |
| 02/12/2015 | WO2015019124A1 Molecular targets for the prevention and/or treatment of fibrosis, hypertrophic scars or keloids |
| 02/12/2015 | WO2015018918A1 Novel nrg1 fusion genes in cancer |
| 02/12/2015 | WO2015018699A1 Molecular targets for the treatment of wounds, in particular chronic wounds |
| 02/12/2015 | WO2015018698A1 Molecular targets for the prevention and/or treatment of fibrosis, hypertrophic scars or keloids |
| 02/12/2015 | WO2015018529A1 Combined pharmaceutical composition |
| 02/12/2015 | WO2015018528A1 Il-15 and il-15raplha sushi domain based modulokines |
| 02/12/2015 | WO2015018459A1 Plants with modified vascular tissue |
| 02/12/2015 | WO2015018376A1 Protein zmwak with high resistance to head smut， encoding gene and use thereof |
| 02/12/2015 | WO2015018359A1 Bg1 compositions and methods to increase agronomic performance of plants |
| 02/12/2015 | WO2015017888A1 Contaminant removal method |
| 02/12/2015 | US20150047060 Transgenic animal model of mood disorders |
| 02/12/2015 | US20150045539 Process for production of fibrinogen and fibrinogen produced thereby |
| 02/12/2015 | US20150045538 MANUFACTURE OF INTER-ALPHA-INHIBITOR (IaIp) FROM PLASMA |
| 02/12/2015 | US20150045537 Extracellular release of lipids by photosynthetic cells |
| 02/12/2015 | US20150045536 Universal carrier for targeting molecules to gb3 receptor expressing cells |
| 02/12/2015 | US20150045535 Bacillus Licheniformis Chromosome |
| 02/12/2015 | US20150045534 Process for the Synthesis of Therapeutic Peptides |
| 02/12/2015 | US20150045506 Native ligation process |
| 02/12/2015 | US20150045310 Novel engineered potent cytotoxic stapled bh3 peptides |
| 02/12/2015 | US20150045308 Compositions and Methods of Treating Cancer |